Vitamin D Testing
Europe
Updated
Reviewed by Vidhi Upadhyay
Europe Breast Pumps Market Industry Trends and Forecast to 2034: Segmented by (Product, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$576.5 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $642.6 Mn | — | — |
| 2025 (base) | $687.6 Mn | +$45.0 Mn | — |
| 2026 (forecast) | $735.8 Mn | +$48.1 Mn | +7% |
| 2027 (forecast) | $787.3 Mn | +$51.5 Mn | +14.5% |
| 2028 (forecast) | $842.4 Mn | +$55.1 Mn | +22.5% |
| 2029 (forecast) | $901.3 Mn | +$59.0 Mn | +31.1% |
| 2030 (forecast) | $964.4 Mn | +$63.1 Mn | +40.3% |
| 2031 (forecast) | $1.03 Bn | +$67.5 Mn | +50.1% |
| 2032 (forecast) | $1.10 Bn | +$72.2 Mn | +60.6% |
| 2033 (forecast) | $1.18 Bn | +$77.3 Mn | +71.8% |
| 2034 (forecast) | $1.26 Bn | +$82.7 Mn | +83.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $687.6 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $1.26 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, use and end user (see all) |
| Key players | Medela, Elvie (Chiaro), Willow Innovations, Philips Avent, Lansinoh and 1 more (see all) |
| Regulator in Europe | EU MDRSource: European Commission, medical devices. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Breast pumps help mothers express breast milk, with manual, electric and wearable models for home and hospital use.
Key segments of the breast Pumps market include product (Wearable Pumps, Electric Pumps and Manual Pumps) and use (Personal Use, Hospital Use and Rental).
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the breast Pumps market. New products designed around women's biology and digital care are improving access.
Femtech, personalised care and new treatments for under-served conditions open strong growth for the breast Pumps market, especially as employers and payers add women's health benefits.
Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the breast Pumps market.
The breast Pumps market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.[1] In the countries we cover here, medical devices are regulated by ANSM (France)[2], BfArM (Germany)[3], Ministry of Health (Italy)[4], Roszdravnadzor (Russia)[5], AEMPS (Spain)[6] and MHRA (UK)[7]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.[8]
[1] European Commission, medical devices. Checked 14 Nov 2026.
[2] ANSM, French medicines agency. Checked 14 Nov 2026.
[3] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.
[4] Italian Ministry of Health. Checked 14 Nov 2026.
[5] Roszdravnadzor. Checked 14 Nov 2026.
[6] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.
[7] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
[8] European Commission, health technology assessment. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how breast Pumps products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.
What doctors and scientists are doing in Breast Pumps right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Europe
Europe
Europe
Europe
Europe
Europe
Pharmaceuticals · Europe
Healthcare Services · Europe
Pharmaceuticals · Europe
Pharmaceuticals · Europe
Pharmaceuticals · Europe
Healthcare Services · Europe